NIH Awards $7M Contract to CDI for iPS Cell Lines, Differentiated Tissue Cells | GenomeWeb

NEW YORK (GenomeWeb News) – Cellular Dynamics International today said that the National Institutes of Health Center for Regenerative Medicine has awarded it a contract for up to $7 million over three years to provide human induced pluripotent stem cell lines and terminally differentiated tissue cells from normal or specified patient populations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.

Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.

DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.

A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.